Interleukin-6 is associated with liver lipid homeostasis but not with cell death in experimental hepatic steatosis

Innate Immunity

Volumn 15, Issue 6, 2009, Pages 337-349

  Sánchez Garrido, Miguel A ^a   Chico, Yolanda ^b   González, Raúl ^a,c   Ranchal, Isidora ^a,c   González Rubio, Sandra ^a   Hidalgo, Ana B ^a   Díaz López, Cesar ^a   Costán, Guadalupe ^a,c   Padillo, Francisco J ^a,c   De La Mata, Manuel ^a,c   Ochoa, Begoña ^b   Muntané, Jordi ^a,c  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Cell death; Hepatic steatosis; Liver phosphatidylcholine; Mitochondrial lipids

Indexed keywords

CARDIOLIPIN; CASPASE 3; CHOLESTEROL; CHOLESTEROL ESTER; CHOLINE; CYTOCHROME C; DNA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; DIET; DNA FRAGMENTATION; ENZYME ACTIVITY; ENZYME RELEASE; FATTY LIVER; HOMEOSTASIS; IN VIVO STUDY; LIPID COMPOSITION; LIPID LIVER LEVEL; LIVER CELL CULTURE; LIVER MITOCHONDRION; MALE; MICROENVIRONMENT; NONHUMAN; RAT; RESPIRATORY CHAIN; SUPPLEMENTATION; VITAMIN DEFICIENCY;

ANIMALS; APOPTOSIS; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; CHOLINE DEFICIENCY; DIET; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELECTRON TRANSPORT; FATTY LIVER; HEPATOCYTES; INTERLEUKIN-6; LIVER; MALE; MITOCHONDRIA, LIVER; PHOSPHATIDYLCHOLINES; RATS; RATS, WISTAR; RECEPTORS, INTERLEUKIN-6; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS;

EID: 74549115240     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425909104900     Document Type: Article

References (60)

1. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994; 272:205-211.
2. Flegal KM, Carroll MD, Kuckmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 1998; 22: 39-47.
3. Braillon A, Capron JP, Herve MA, Degott C, Quenum C. Liver in obesity. Gut 1984; 26: 133-139.
4. 4. Andersen T, Gluud C. Liver morphology in morbid obesity: a literature study. Int J Obes 1984; 8: 97-106. (Pubitemid 14130603)
5. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri. BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107: 1103-1109.
6. 6. Gao D, Wei C, Chen L, Huang J, Yang S, Diehl AM. Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease. Am J Physiol 2004; 287: G1070-G1077. (Pubitemid 39423700)
7. Pessayre D, Berson A, Fromenty B, Mansouri A. Mitochondria in steatohepatitis. Semin Liver Dis 2001; 21: 57-69.
8. Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995; 22: 1714-1719.
9. Diehl AM. Lessons from animal models of NASH. Hepatol Res 2005; 33: 138-144.
10. 10. Tracey KJ, Cerami. A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993; 9: 317-343. (Pubitemid 2021154)
11. Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. Hepatology 1991; 13: 364-375.
12. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111-1119.
13. Hotamisligil GS, Spiegel man BM. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994; 43: 1271-1278.
14. 14. Shiba T, Higashi N, Nishimura Y. Hyperglycaemia due to insulin resistance caused by interferon-gamma. Diabet Med 1998; 15: 435-436. (Pubitemid 28197114)
15. Uysal. KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997; 389: 610-614.
16. 16. Garcia-Galiano D, Sánchez-Garrido MA, Espejo I et al. IL-6 and IGF-I are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbid obese patients. Obes Surg 2007; 17: 493-503. (Pubitemid 46850189)
17. Wieckowska A, Papouchado BG, Li. Z, López R, Zein NN, Feldstein AE. Increased hepatic and circulating interleukin-6 levels in human non-alcoholic steatohepatitis. Am J Gastroenterol 2008; 103: 1-8.
18. 18. Alwayn IP, Andersson CH, Lee S et al. Inhibition of matrix metalloproteinases increases PPAR-a and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model. Am J Physiol 2006; 291: G1011-G1019. (Pubitemid 44904155)
19. 19. Vetelainen R, Van VA, Gouma DJ, Van Gulik TM. Steatosis as a risk factor in liver surgery. Ann Surg 2007; 245: 20-30. (Pubitemid 46035431)
20. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976; 13: 29-83.
21. Magalhâes PJ, Andreu AL, Schon EA. Evidence for the presence of 5S rRNA in mammalian mitochondria. Mol Biol Cell 1998; 9: 2375-2382.
22. Schreiber E, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 1989; 17: 6419.
23. 23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(t)) method. Methods 2001; 25: 402-408. (Pubitemid 34164012)
24. 24. Ruiz JI, Ochoa B. Quantification in the subnanomolar range of phospholipids and neutral lipids by monodimensional thin-layer chromatography and image analysis. J Lipid Res 1997; 38: 1482-1489. (Pubitemid 27332574)
25. 25. Birch-Machin MA, Turnbull DM. Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. Methods Cell Biol 2001; 65: 97-117. (Pubitemid 33798115)
26. Li Z, Agellon LB, Allen TM et al. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab 2006; 3: 321-331,
27. 27. Petrosillo G, Portincasa P, Grattagliano I et al. Mitochondrial dysfunction in rat with nonalcoholic fatty liver. Involvement of complex I. oxygen species and cardiolipin. Biochim Biophys Acta 2007; 1767: 1260-1267. (Pubitemid 47498313)
28. 28. Colell A, Garcia-Ruiz C, Miranda M et al. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology 1998; 115: 1541-1551. (Pubitemid 28546006)
29. 29. Kovalovich K, Li W, Deangelis R, Greenbaum LE, Ciliberto G, Taub R. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J Biol Chem 2001; 276: 26605-26613. (Pubitemid 37412883)
30. 30. Streetz KL, Tacke F, Leifeld L et al. Interleukin 6/gp130dependent pathways are protective during chronic liver diseases. Hepatology 2003; 38: 218-229. (Pubitemid 36775814)
31. 31. Camargo CA, Madden JF, Gao W, Selvan RS, Clavien PA. Interleukin-6 protects liver against warm, ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997; 26: 1513-1520. (Pubitemid 27520017)
32. 32. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 1986; 6: 97-106. (Pubitemid 16010551)
33. 33. Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20: 829-838. (Pubitemid 24296488)
34. 34. Tsukamoto H, Lu SC. Current concepts in the pathogenesis of alcoholic liver injury. FASEB J 2001; 15: 1335-1349. (Pubitemid 32531812)
35. 35. Donthamsetty S, Bhave VS, Mitra MS, Latendresse JR, Mehendale HM. Nonalcoholic fatty liver sensitizes rats to carbon tetrachloride hepatotoxicity. Hepatology 2007; 45: 391-403. (Pubitemid 46374596)
36. Simons K, Van Meer G. Lipid sorting in epithelial cells. Biochemistry 1988; 27: 6197-6202.
37. Yao Z, Vance DE. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem 1998; 263: 2998-3004.
38. 38. Ghoshal AK, Färber E. Choline deficiency, lipotrope deficiency and the development of liver disease including liver cancer: a new perspective. Lab Invest 1993; 68: 255-260. (Pubitemid 23097646)
39. 39. Amore A, Coppo R, Roccatello D et al. Experimental IgA nephropathy secondary to hepatocellular injury induced by dietary deficiencies and heavy alcohol intake. Lab Invest 1994; 70: 68-77. (Pubitemid 24080106)
40. Zeisel SH, Blusztajn JK. Choline and human nutrition. Annu Rev Nutr 1994; 14: 269-296.
41. Vance DE, Ridgway ND. The methylation of phosphatidylethanolamine. Prog Lipid Res 1988; 27: 61-79.
42. Li Z, Vance DE. Phosphatidylcholine and choline homeostasis. J Lipid Res 2008; 49: 1187-1194.
43. 43. Kulinski A, Vance DE, Vance JE. A choline-deficient diet in mice inhibits neither the CDP-choline pathway for phosphatidylcholine synthesis in hepatocytes nor apolipoprotein B secretion. J Biol Chem 2004; 279: 23916-23924. (Pubitemid 38725249)
44. 44. Lenaz G, Bovina C, D'Aurelio M et al. Role of mitochondria in oxidative stress and aging. Ann NY Acad Sci 2002; 959: 199-213. (Pubitemid 34457563)
45. 45. Mari M, Caballero F, Colell A et al. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab 2006; 4: 185-198. (Pubitemid 44307975)
46. Fernández-Real JM, Pickup JC. Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2007; 19: 10-16.
47. 47. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 1993; 268: 26055-26058. (Pubitemid 2013440)
48. 48. Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 2002; 51: 3391-3399. (Pubitemid 35403441)
49. Stephan N, Kantartzis K, Häring H-U. Causes and metabolic consequences of fatty liver. Endrocrine Rev 2008; 29: 939-960.
50. 50. Nieto N, Rojkind M. Repeated whiskey binges promote liver injury in rats fed a choline-deficient diet. J Hepatol 2007; 46: 330-339. (Pubitemid 44959157)
51. Sabio G, Das M, Mora A et al. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 2008; 322: 1539-1543.
52. 52. Hong F, Radaeva S, Pan HN, Tian Z, Veech R, Gao B. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hepatology 2004; 40: 933-941. (Pubitemid 39288127)
53. Perez S, Aspichueta P, Ochoa B, Chico Y. The 2-series prostaglandins suppress VLDL secretion in an inflammatory condition-dependent manner in primary rat hepatocytes. Biochim BiophysActa 2006; 1761: 160-171.
54. Bartolomé N, Arteta B, Martínez MJ, Chico Y, Ochoa B. Kupffer cell products and interleukin 1β directly promote VLDL secretion and apoB mRNA up-regulation in rodent hepatocytes. Innate Immun 2008; 14: 255-266.
55. 55. Tazuke Y, Drongowski RA, Teitelbaum DH, Coran AG. Interleukin-6 changes tight junction permeability and intracellular phospholipid content in a human enterocyte cell culture model. Pediatr Surg Int 2003; 19: 321-325. (Pubitemid 37046190)
56. Spangelo BL, Jarvis WD, Judd AM, Macleod RM. Induction of interleukin-6 release by interleukin-,1 in rat anterior pituitary cells in vitro: evidence for an eicosanoid-dependent mechanism. Endocrinology 1991; 129: 2886-2894.
57. Cressman DE, Greenbaum LE, Deangelis RA et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274: 1379-1383.
58. Taub R, Greenbaum. LE, Peng Y. Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration. Semin Liver Dis 1999; 19: 117-1.27.
59. Treede I, Braun A, Sparla R et al. Anti-inflammatory effects of phosphatidylcholine. J Biol Chem 2007; 282: 27155-27164.
60. 60. Mourelle M, Guamer F, Malagelada JR. Polyunsaturated phosphatidylcholine prevents stricture formation in a rat model of colitis. Gastroenterology 1996; 110: 1093-1097. (Pubitemid 26113749)